Report Detail
Global Gene Therapy For Cancer Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4511860 |
- 16 February, 2023 |
- Global |
- 86 Pages |
- GIR (Global Info Research) |
- Other
Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression.
According to our (Global Info Research) latest study, the global Gene Therapy For Cancer market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Gene Therapy For Cancer market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gene Therapy For Cancer market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gene Therapy For Cancer market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gene Therapy For Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gene Therapy For Cancer market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Therapy For Cancer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Therapy For Cancer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GLIEAD, REGENXBIO, Autolus, American Gene Technologies and Arcellx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Gene Therapy For Cancer market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Rb Gene
P53 Gene
APC Gene
NF1 Gene
Others
Market segment by Application
Cancer Treatment
Tissue Repair
Others
Market segment by players, this report covers
GLIEAD
REGENXBIO
Autolus
American Gene Technologies
Arcellx
AUSTRIANOVA
Alphavax
Cellectis
Chimeron
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy For Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy For Cancer, with revenue, gross margin and global market share of Gene Therapy For Cancer from 2018 to 2023.
Chapter 3, the Gene Therapy For Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Therapy For Cancer market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy For Cancer.
Chapter 13, to describe Gene Therapy For Cancer research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Gene Therapy For Cancer
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Gene Therapy For Cancer by Type
- 1.3.1 Overview: Global Gene Therapy For Cancer Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Gene Therapy For Cancer Consumption Value Market Share by Type in 2022
- 1.3.3 Rb Gene
- 1.3.4 P53 Gene
- 1.3.5 APC Gene
- 1.3.6 NF1 Gene
- 1.3.7 Others
- 1.4 Global Gene Therapy For Cancer Market by Application
- 1.4.1 Overview: Global Gene Therapy For Cancer Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Cancer Treatment
- 1.4.3 Tissue Repair
- 1.4.4 Others
- 1.5 Global Gene Therapy For Cancer Market Size & Forecast
- 1.6 Global Gene Therapy For Cancer Market Size and Forecast by Region
- 1.6.1 Global Gene Therapy For Cancer Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Gene Therapy For Cancer Market Size by Region, (2018-2029)
- 1.6.3 North America Gene Therapy For Cancer Market Size and Prospect (2018-2029)
- 1.6.4 Europe Gene Therapy For Cancer Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Gene Therapy For Cancer Market Size and Prospect (2018-2029)
- 1.6.6 South America Gene Therapy For Cancer Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Gene Therapy For Cancer Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 GLIEAD
- 2.1.1 GLIEAD Details
- 2.1.2 GLIEAD Major Business
- 2.1.3 GLIEAD Gene Therapy For Cancer Product and Solutions
- 2.1.4 GLIEAD Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 GLIEAD Recent Developments and Future Plans
- 2.2 REGENXBIO
- 2.2.1 REGENXBIO Details
- 2.2.2 REGENXBIO Major Business
- 2.2.3 REGENXBIO Gene Therapy For Cancer Product and Solutions
- 2.2.4 REGENXBIO Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 REGENXBIO Recent Developments and Future Plans
- 2.3 Autolus
- 2.3.1 Autolus Details
- 2.3.2 Autolus Major Business
- 2.3.3 Autolus Gene Therapy For Cancer Product and Solutions
- 2.3.4 Autolus Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Autolus Recent Developments and Future Plans
- 2.4 American Gene Technologies
- 2.4.1 American Gene Technologies Details
- 2.4.2 American Gene Technologies Major Business
- 2.4.3 American Gene Technologies Gene Therapy For Cancer Product and Solutions
- 2.4.4 American Gene Technologies Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 American Gene Technologies Recent Developments and Future Plans
- 2.5 Arcellx
- 2.5.1 Arcellx Details
- 2.5.2 Arcellx Major Business
- 2.5.3 Arcellx Gene Therapy For Cancer Product and Solutions
- 2.5.4 Arcellx Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Arcellx Recent Developments and Future Plans
- 2.6 AUSTRIANOVA
- 2.6.1 AUSTRIANOVA Details
- 2.6.2 AUSTRIANOVA Major Business
- 2.6.3 AUSTRIANOVA Gene Therapy For Cancer Product and Solutions
- 2.6.4 AUSTRIANOVA Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 AUSTRIANOVA Recent Developments and Future Plans
- 2.7 Alphavax
- 2.7.1 Alphavax Details
- 2.7.2 Alphavax Major Business
- 2.7.3 Alphavax Gene Therapy For Cancer Product and Solutions
- 2.7.4 Alphavax Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Alphavax Recent Developments and Future Plans
- 2.8 Cellectis
- 2.8.1 Cellectis Details
- 2.8.2 Cellectis Major Business
- 2.8.3 Cellectis Gene Therapy For Cancer Product and Solutions
- 2.8.4 Cellectis Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Cellectis Recent Developments and Future Plans
- 2.9 Chimeron
- 2.9.1 Chimeron Details
- 2.9.2 Chimeron Major Business
- 2.9.3 Chimeron Gene Therapy For Cancer Product and Solutions
- 2.9.4 Chimeron Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Chimeron Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Gene Therapy For Cancer Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Gene Therapy For Cancer by Company Revenue
- 3.2.2 Top 3 Gene Therapy For Cancer Players Market Share in 2022
- 3.2.3 Top 6 Gene Therapy For Cancer Players Market Share in 2022
- 3.3 Gene Therapy For Cancer Market: Overall Company Footprint Analysis
- 3.3.1 Gene Therapy For Cancer Market: Region Footprint
- 3.3.2 Gene Therapy For Cancer Market: Company Product Type Footprint
- 3.3.3 Gene Therapy For Cancer Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Gene Therapy For Cancer Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Gene Therapy For Cancer Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Gene Therapy For Cancer Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Gene Therapy For Cancer Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Gene Therapy For Cancer Consumption Value by Type (2018-2029)
- 6.2 North America Gene Therapy For Cancer Consumption Value by Application (2018-2029)
- 6.3 North America Gene Therapy For Cancer Market Size by Country
- 6.3.1 North America Gene Therapy For Cancer Consumption Value by Country (2018-2029)
- 6.3.2 United States Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 6.3.3 Canada Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Gene Therapy For Cancer Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Gene Therapy For Cancer Consumption Value by Type (2018-2029)
- 7.2 Europe Gene Therapy For Cancer Consumption Value by Application (2018-2029)
- 7.3 Europe Gene Therapy For Cancer Market Size by Country
- 7.3.1 Europe Gene Therapy For Cancer Consumption Value by Country (2018-2029)
- 7.3.2 Germany Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 7.3.3 France Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 7.3.5 Russia Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 7.3.6 Italy Gene Therapy For Cancer Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Gene Therapy For Cancer Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Gene Therapy For Cancer Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Gene Therapy For Cancer Market Size by Region
- 8.3.1 Asia-Pacific Gene Therapy For Cancer Consumption Value by Region (2018-2029)
- 8.3.2 China Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 8.3.3 Japan Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 8.3.5 India Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 8.3.7 Australia Gene Therapy For Cancer Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Gene Therapy For Cancer Consumption Value by Type (2018-2029)
- 9.2 South America Gene Therapy For Cancer Consumption Value by Application (2018-2029)
- 9.3 South America Gene Therapy For Cancer Market Size by Country
- 9.3.1 South America Gene Therapy For Cancer Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Gene Therapy For Cancer Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Gene Therapy For Cancer Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Gene Therapy For Cancer Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Gene Therapy For Cancer Market Size by Country
- 10.3.1 Middle East & Africa Gene Therapy For Cancer Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Gene Therapy For Cancer Market Size and Forecast (2018-2029)
- 10.3.4 UAE Gene Therapy For Cancer Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Gene Therapy For Cancer Market Drivers
- 11.2 Gene Therapy For Cancer Market Restraints
- 11.3 Gene Therapy For Cancer Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Gene Therapy For Cancer Industry Chain
- 12.2 Gene Therapy For Cancer Upstream Analysis
- 12.3 Gene Therapy For Cancer Midstream Analysis
- 12.4 Gene Therapy For Cancer Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Gene Therapy For Cancer. Industry analysis & Market Report on Gene Therapy For Cancer is a syndicated market report, published as Global Gene Therapy For Cancer Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Gene Therapy For Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
